Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 8Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Melanoma 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Recurrence 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Locally Advanced Cervical Cancer 1Gestational Trophoblastic Disease 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

Cisplatin 7Radiotherapy 3Paclitaxel 3Carboplatin 3Brachytherapy 2zimberelimab 1piperine 1pembrolizumab 1durvalumab 1camrelizumab 1atezolizumab 1Sodium Chloride 1Neoadjuvant Therapy 1Gemcitabine 1Drug Therapy 1Curcumin 1Chemoradiotherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Cancer × zimberelimab × Gynecologic × Clear all
NCT06055738 2023-09-28

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Tang-Du Hospital

Phase 2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡